5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.17▲ | 1.16▲ | 1.16▲ | 1.18▲ | 1.16▲ |
MA10 | 1.16▲ | 1.16▲ | 1.16▲ | 1.19▼ | 1.34▼ |
MA20 | 1.16▲ | 1.15▲ | 1.16▲ | 1.15▲ | 1.56▼ |
MA50 | 1.16▲ | 1.19▼ | 1.17▲ | 1.45▼ | 1.29▼ |
MA100 | 1.23▼ | 1.16▲ | 1.16▲ | 1.56▼ | 1.19▼ |
MA200 | 1.19▼ | 1.19▼ | 1.39▼ | 1.32▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.004▲ | 0.003▲ | 0.028▲ | -0.085▼ |
RSI | 57.247▲ | 53.767▲ | 53.332▲ | 46.423▼ | 44.394▼ |
STOCH | 54.167 | 58.333 | 61.574 | 21.126 | 15.266▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -77.670▼ | -85.349▼ |
CCI | 161.538▲ | 158.848▲ | 162.353▲ | 6.563 | -68.364 |
Wednesday, September 10, 2025 11:30 AM
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced positive ...
|
Tuesday, September 02, 2025 09:10 AM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Neurosense Therapeutics Ltd. ( (NRSN)) ...
|
Thursday, August 21, 2025 05:24 PM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Neurosense Therapeutics Ltd. ( (NRSN)) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 1.12 | 1.20 | 1.12 | 1.18 | 170,718 |
16/09/25 | 1.11 | 1.18 | 1.11 | 1.17 | 221,207 |
15/09/25 | 1.22 | 1.22 | 1.11 | 1.16 | 551,131 |
12/09/25 | 1.21 | 1.275 | 1.18 | 1.22 | 2,129,037 |
11/09/25 | 1.24 | 1.25 | 1.14 | 1.15 | 1,413,358 |
10/09/25 | 1.1599 | 1.98 | 1.155 | 1.36 | 18,812,186 |
09/09/25 | 1.15 | 1.17 | 1.10 | 1.17 | 67,828 |
08/09/25 | 1.19 | 1.25 | 1.12 | 1.16 | 221,510 |
05/09/25 | 1.10 | 1.20 | 1.08 | 1.18 | 195,680 |
04/09/25 | 1.10 | 1.12 | 1.02 | 1.10 | 1,032,123 |
|
|
||||
|
|
||||
|
|